FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 5.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $265,000 | +48.9% | 56,422 | -28.2% | 0.04% | -2.2% |
| Q1 2020 | $178,000 | -61.6% | 78,534 | -22.1% | 0.04% | -16.7% |
| Q4 2019 | $463,000 | +332.7% | 100,876 | +265.1% | 0.05% | +285.7% |
| Q3 2019 | $107,000 | -10.1% | 27,626 | +39.8% | 0.01% | +7.7% |
| Q2 2019 | $119,000 | -72.1% | 19,767 | -35.4% | 0.01% | -45.8% |
| Q3 2018 | $426,000 | -26.7% | 30,600 | -9.5% | 0.02% | -22.6% |
| Q1 2018 | $581,000 | -29.8% | 33,800 | +22.9% | 0.03% | -42.6% |
| Q2 2017 | $828,000 | -48.1% | 27,500 | -37.6% | 0.05% | -37.2% |
| Q1 2017 | $1,594,000 | -56.0% | 44,100 | -39.0% | 0.09% | -60.4% |
| Q4 2016 | $3,622,000 | -2.8% | 72,279 | +1.8% | 0.22% | +8.5% |
| Q3 2016 | $3,727,000 | -4.5% | 71,000 | -24.8% | 0.20% | -7.4% |
| Q2 2016 | $3,904,000 | +5.7% | 94,425 | +3.9% | 0.22% | -8.1% |
| Q1 2016 | $3,692,000 | +23.2% | 90,862 | +25.8% | 0.24% | +59.9% |
| Q4 2015 | $2,996,000 | +199.0% | 72,200 | +10.9% | 0.15% | +200.0% |
| Q3 2015 | $1,002,000 | +235.1% | 65,114 | +441.3% | 0.05% | +345.5% |
| Q2 2015 | $299,000 | -66.4% | 12,029 | -69.1% | 0.01% | -68.6% |
| Q1 2015 | $889,000 | – | 38,896 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|